RGEN
HEALTHCARERepligen Corp
$125.76+0.15 (+0.12%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving RGEN Today?
No stock-specific AI insight has been generated for RGEN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$109.50$175.77
$125.76
Fundamentals
Market Cap$7.1B
P/E Ratio139.7
EPS$0.90
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding56.4M
RGEN News
20 articles- Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare ConferenceYahoo Finance·May 7, 2026
- Repligen's Q1 Earnings & Revenues Beat Estimates, Stock RisesYahoo Finance·May 6, 2026
- Repligen Reshapes Operations And China Reach As Valuation Signals UpsideYahoo Finance·May 6, 2026
- Repligen Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- Repligen Corporation Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- Repligen (RGEN) Q1 2026 Earnings Call TranscriptMotley Fool·May 5, 2026
- Repligen (RGEN) Q1 Earnings and Revenues Beat EstimatesYahoo Finance·May 5, 2026
- Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat EstimatesYahoo Finance·May 5, 2026
- Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceYahoo Finance·May 5, 2026
- Repligen (RGEN) Q1 Earnings Report Preview: What To Look ForYahoo Finance·May 4, 2026
- Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseYahoo Finance·Apr 30, 2026
- Is Repligen (RGEN) Starting To Look Attractive After Its Sharp Share Price PullbackYahoo Finance·Apr 30, 2026
- Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out forYahoo Finance·Apr 28, 2026
- Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1Yahoo Finance·Apr 27, 2026
- Why Repligen (RGEN) Shares Are Plunging TodayYahoo Finance·Apr 23, 2026
- Repligen to Report First Quarter 2026 Financial ResultsYahoo Finance·Apr 22, 2026
- Assessing Repligen (RGEN) Valuation After Recent Share Price ReboundYahoo Finance·Apr 21, 2026
- 908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Apr 21, 2026
- Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term GrowthYahoo Finance·Apr 20, 2026
- Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To KnowYahoo Finance·Apr 18, 2026
All 20 articles loaded
Price Data
Open$129.32
Previous Close$125.61
Day High$131.53
Day Low$125.21
52 Week High$175.77
52 Week Low$109.50
52-Week Range
$109.50$175.77
$125.76
Fundamentals
Market Cap$7.1B
P/E Ratio139.7
EPS$0.90
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding56.4M
About Repligen Corp
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—